FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - RENAL PELVIS AND URETER





Form # 785-1-048

 CLIN PATH  DEFINITIONS
    PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

Ta Papillary noninvasive carcinoma

Tis Carcinoma in situ

T1 Tumor invades subepithelial connective tissue

T2 Tumor invades muscularis

T3 Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (For renal pelvis only)

T3 Tumor invades beyond muscularis into periureteric fat (For ureter only)

T4 Tumor invades adjacent organs or through the kidney into parinephric fat

LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Metastasis in a single lymph node, 2 cm or less in greatest dimension

N2 Merastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension, or multiple lymph nodes, none more than 5 cm in greatest dimension

N3 Metastasis in a lymph node more than 5 cm in greatest dimension
    DISTANT METASTASIS (M)

MX Presence of disatant metastasis cannot be assessed

M1 No disatant metastasis

M1 Disatant metastasis

Pathologic Stage by: M.D. Date:

 CLIN PATH  STAGE GROUPING

0a Ta N0 M0

0is Tis N0 M0

I T1 N0 M0

II T2 N0 M0

III T3 N0 M0

IV T4 N0 M0
      Any T N1 M0
      Any T N2 M0
      Any T N3 M0
      Any T Any N M1

Attending: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:

Patient Name: